Korro Bio, Inc.

KRRO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$18,061-$25,770-$23,387-$21,199
Dep. & Amort.$1,200$1,200$1,225$1,253
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$2,253$3,148-$3,869$11,177
Other Non-Cash$1,935$2,194$1,579$1,274
Operating Cash Flow-$17,179-$19,228-$24,452-$7,495
Investing Activities
PP&E Inv.-$175-$140-$119-$1,452
Net Acquisitions$0$0$0$0
Inv. Purchases-$15,028-$11,161$0-$28,213
Inv. Sales/Matur.$22,799$1$32,900$26,900
Other Inv. Act.$0$0$0$0
Investing Cash Flow$7,596-$11,300$32,781-$2,765
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$128$5$172$932
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$128$5$172$932
Forex Effect-$2$991$0-$4
Net Chg. in Cash-$9,457-$29,532$8,501-$9,332
Supplemental Information
Beg. Cash$34,612$64,144$55,643$64,975
End Cash$25,155$34,612$64,144$55,643
Free Cash Flow-$17,354-$19,368-$24,571-$8,947